WHITE PLAINS, NY -- (Marketwired) -- 12/03/13 -- Orgenesis, Inc. (OTCQB: ORGS), a development-stage company with a novel regenerative medicine technology that converts a diabetes patient's liver cells into functioning insulin-producing cells, has been invited to present at the 2013 World Stem Cell ...
↧